DEXKETOPROFEN
Intracerebral Hemorrhage
Beijing Tiantan HospitalSmall moleculePhase 2/3Active
B
58/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 81/ 100
Competitive context
23 Active assets in the Intracerebral Hemorrhage cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NEPENTHE Henry M. Jackson Foundation for the Advancement of Military Medicine | Phase 4 | BB |
Dabigatran Imperial College London | Phase 3 | B |
Rivaroxaban Imperial College London | Phase 3 | B |
Apixaban Region Stockholm | Phase 3 | B |
PROPRANOLOL Tang-Du Hospital | Phase 2/3 | B |
View all 42 →
Same molecule, other indications
DEXKETOPROFEN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →